GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

SP-0230 is under clinical development by Sanofi and currently in Phase II for Neisseria meningitidis Infections.

Efficacy and Safety of Paracetamol, Phenylephrine and Chlorpheniramine maleate FDC in Common Cold - ...

Sanofi's SNY short percent of float has fallen 15.0% since its last report. The company recently reported that it has 3.74 ...

The increases are to list prices, which do not include rebates to pharmacy benefit managers and other discounts.

State Street Corp raised its holdings in Sanofi (NASDAQ:SNY – Free Report) by 0.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The ...

Sanofi (NASDAQ:SNY – Get Free Report) saw a large decline in short interest in the month of December. As of December 15th, there was short interest totalling 3,740,000 shares, a decline of 17.4% from ...

Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, ...

In separate DLL3 antibody-drug conjugate (ADC) deals, Roche licensed from Innovent Biologics and Ideaya reached for Hengrui.

Biotech giant Regeneron Pharmaceuticals (NASDAQ: REGN) started 2024 on a strong note and performed well through the first ...

Researchers design a new way to more reliably evaluate AI models' ability to make clinical decisions in realistic scenarios that closely mimic real-life interactions. The analysis finds that ...

By adapting artificial intelligence models known as large language models, researchers have made great progress in their ...